Recent advances in the treatment of Amblyopia

Pediatrics

Volumn 113, Issue 6 I, 2004, Pages 1800-1802

  Quinn, Graham E ^a,b   Beck, Roy W ^c   Holmes, Jonathan M ^d   Repka, Michael X ^e  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JAEB CENTER FOR HEALTH RESEARCH   (United States)

^d Mayo Clinic   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE;

ALGORITHM; AMBLYOPIA; ANISOMETROPIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MONOCULAR VISION; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRABISMUS; TIME; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; AMBLYOPIA; ANISOMETROPIA; ATROPINE; CHILD; CHILD, PRESCHOOL; HUMANS; MYDRIATICS; RANDOMIZED CONTROLLED TRIALS; SENSORY DEPRIVATION; STRABISMUS; TIME FACTORS; VISUAL ACUITY;

EID: 2542626732     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.6.1800     Document Type: Note

References (17)

1. Beck RW. Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group. Curr Opin Ophthalmol. 2002;13:337-340
2. Beck RW. The Pediatric Eye Disease Investigator Group. J AAPOS. 1998;2:255-256
3. National Eye Institute Office of Biometry and Epidemiology. Report on the National Eye Institute's Visual Acuity Impairment Survey Pilot Study. Washington, DC: Department of Health and Human Services; 1984
4. Simons K. Preschool vision screening: rationale, methodology and outcome. Surv Ophthalmol. 1996;41:3-30
5. Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology. 2003;110:1632-1638
6. Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol. 2002;120:281-287
7. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-78
8. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the Amblyopia Treatment Study. Am J Ophthalmol. 2003;136:630-639
9. Holmes JM, Beck RW, Kraker RT, et al. The impact of patching and atropine on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121:1625-1632
10. Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol. 2001;119:1345-1353
11. Moke PS, Turpin AH, Beck RW, et al. Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol. 2001;132:903-909
12. Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96
13. Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 203;121:603-611
14. Holmes JM, Kraker RT, Beck RW, et al. A randomized trial of patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075-2087
15. Pediatric Eye Disease Investigator Group. A prospective, pilot study of treatment of amblyopia in children 10 to <18 years old. Am J Ophthalmol. 2004;137:581-583
16. Cotter SA, Chu RH, Chandler DL, et al. Reliability of the Electronic Early Treatment Diabetic Retinopathy Study testing protocol in children 7 to <13 years old. Am J Ophthalmol. 2003;136:655-661
17. Beck R, Moke P, Turpin A, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135:194-205